MARKET

GENE

GENE

Genetic Technologies
NASDAQ
0.7097
+0.0040
+0.57%
Opening 14:19 11/28 EST
OPEN
0.7250
PREV CLOSE
0.7057
HIGH
0.7250
LOW
0.6900
VOLUME
30.48K
TURNOVER
0
52 WEEK HIGH
2.400
52 WEEK LOW
0.6600
MARKET CAP
13.65M
P/E (TTM)
-1.5308
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at GENE last week (1120-1124)?
Weekly Report · 1d ago
Genetic Technologies: Report of foreign issuer
Press release · 4d ago
Genetic Technologies: Report of foreign issuer
Press release · 11/21 16:02
Weekly Report: what happened at GENE last week (1113-1117)?
Weekly Report · 11/20 10:56
Cannabis Stock Movers For November 13, 2023
Auscann group holdings shares closed up 66.67% at $0.00. Auxly cannabis group shares close up 46.94%. Evio shares closed down 98.00% as the company continues to struggle in the market. Cresco labs and eastside distilling close up 20.87%.
Benzinga · 11/13 21:30
Weekly Report: what happened at GENE last week (1106-1110)?
Weekly Report · 11/13 10:50
Weekly Report: what happened at GENE last week (1030-1103)?
Weekly Report · 11/06 10:54
Genetic Technologies: Report of foreign issuer
Press release · 10/30 13:01
More
About GENE
Genetic Technologies Limited (GTG) is an Australia-based molecular diagnostics company. The Company offers predictive genetic testing and risk assessment tools. The Company is engaged in providing genomics-based tests on health, wellness and serious disease through its GeneType and EasyDNA brands. The Company operates through three segments: EasyDNA, AffinityDNA, and geneType / Corporate. The EasyDNA segment relates to EasyDNA branded test sales and expenses. The AffinityDNA segment relates to AffinityDNA branded test sales and expenses. The geneType / Corporate segment relates to geneType branded test sales and expenses, including corporate charges. The GeneType test is for breast cancer, colorectal cancer, ovarian cancer, prostate cancer, coronary artery disease and type two diabetes in a single test. GeneType also offers integrated risk testing for a range of serious conditions. EasyDNA and AffinityDNA offer deoxyribonucleic acid (DNA) testing services.

Webull offers Genetic Technologies Limited (ADR) stock information, including NASDAQ: GENE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GENE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GENE stock methods without spending real money on the virtual paper trading platform.